Question 1

What are the potential side effects of the treatments being tested?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer clinical trial (NCT06394804). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this combination compare to other treatment options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer clinical trial (NCT06394804). Contact the study team or your healthcare provider for specific answers.

Question 3

What will my treatment schedule look like, and how often will I need to come in for visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer clinical trial (NCT06394804). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific tests or procedures I will need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer clinical trial (NCT06394804). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer clinical trial (NCT06394804). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my overall health be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer clinical trial (NCT06394804). Contact the study team or your healthcare provider for specific answers.

What this study is about